Expression of human aldo-keto reductase 1C2 in cell lines of peritoneal endometriosis: Potential implications in metabolism of progesterone and dydrogesterone and inhibition by progestins

Journal of Steroid Biochemistry and Molecular Biology

Volumn 130, Issue 1-2, 2012, Pages 16-25

  Beranič, Nataša ^a   Brožič, Petra ^a   Brus, Boris ^a   Sosič, Izidor ^a   Gobec, Stanislav ^a   Rižner, Tea Lanišnik ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

20 Hydroxysteroid dehydrogenase; 20 Dihydrodydrogesterone; Dydrogesterone; Medroxyprogesterone acetate; Progesterone; Progesterone metabolism

Indexed keywords

20ALPHA DIHYDRODYDROGESTERONE; 20ALPHA HYDROXYSTEROID DEHYDROGENASE; ALDOKETOREDUCTASE 1C3; DANAZOL; DESOGESTREL; DYDROGESTERONE; GESTAGEN; LEVONORGESTREL; LITHOCHOLIC ACID; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; PROGESTERONE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ARTICLE; CATALYSIS; CELL CULTURE; CHEMICAL STRUCTURE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENDOMETRIOSIS; ENZYME ACTIVE SITE; ENZYME PURIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR DOCKING; PERITONEUM; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STEROID METABOLISM;

CATALYTIC DOMAIN; CELL LINE; DIHYDROTESTOSTERONE; DYDROGESTERONE; ENDOMETRIOSIS; FEMALE; HUMANS; HYDROXYSTEROID DEHYDROGENASES; MODELS, MOLECULAR; PERITONEUM; PROGESTERONE; PROGESTINS;

EID: 84859235742     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2011.12.011     Document Type: Article

References (38)

1. L.C. Giudice, L.C. Kao, and Endometriosis Lancet 364 2004 1789 1799
2. A.W. Nap, P.G. Groothuis, A.Y. Demir, J.L. Evers, and G.A. Dunselman Pathogenesis of endometriosis Best Pract. Res. Clin. Obstet. Gynaecol. 18 2004 233 244 (Pubitemid 38786630)
3. L. Story, and S. Kennedy C. Sutton, D. Adamson, K.D. Jones, Etiology of endometriosis 2005 Informa Healthcare 17 24
4. T. Lanišnik Rižner Estrogen metabolism and action in endometriosis Mol. Cell. Endocrinol. 307 2009 8 18
5. A. Kauppila Reappraisal of progestins in endometriosis therapy Eur. J. Endocrinol. 138 1998 134 136 (Pubitemid 28131088)
6. P. Vercellini, L. Fedele, G. Pietropaolo, G. Frontino, E. Somigliana, and P.G. Crosignani Progestogens for endometriosis: forward to the past Hum. Reprod. Update 9 2003 387 396 (Pubitemid 36987285)
7. R. Sitruk-Ware New progestogens: a review of their effects in perimenopausal and postmenopausal women Drugs Aging 21 2004 865 883 (Pubitemid 39487071)
8. A.E. Schindler, C. Campagnoli, R. Druckmann, J. Huber, J.R. Pasqualini, K.W. Schweppe, and J.H. Thijssen Classification and pharmacology of progestins Maturitas 61 2008 171 180
9. K.W. Schweppe Current place of progestins in the treatment of endometriosis-related complaints Gynecol. Endocrinol. 15 2001 22 28
10. S. Ferrero, P.L. Venturini, N. Ragni, G. Camerini, and V. Remorgida Pharmacological treatment of endometriosis: experience with aromatase inhibitors Drugs 69 2009 943 952
11. D. Colombo, P. Ferraboschi, P. Prestileo, and L. Toma A comparative molecular modeling study of dydrogesterone with other progestational agents through theoretical calculations and nuclear magnetic resonance spectroscopy J. Steroid Biochem. Mol. Biol. 98 2006 56 62 (Pubitemid 43113245)
12. N. Beranič, S. Gobec, and T. Lanišnik Rižner Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3 Chem. Biol. Interact. 191 2011 227 233
13. N. Hevir, K. Vouk, J. Šinkovec, M. Ribič-Pucelj, and T. Lanišnik Rižner Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis Chem. Biol. Interact. 191 2011 217 226
14. T.M. Penning, M.E. Burczynski, J.M. Jez, C.F. Hung, H.K. Lin, H. Ma, M. Moore, N. Palackal, and K. Ratnam Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones Biochem. J. 351 2000 67 77
15. Y. Higaki, N. Usami, S. Shintani, S. Ishikura, O. El-Kabbani, and A. Hara Selective and potent inhibitors of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone Chem. Biol. Interact. 143-144 2003 503 513 (Pubitemid 36253599)
16. N. Usami, T. Yamamoto, S. Shintani, S. Ishikura, Y. Higaki, Y. Katagiri, and A. Hara Substrate specificity of human 3(20)alpha-hydroxysteroid dehydrogenase for neurosteroids and its inhibition by benzodiazepines Biol. Pharm. Bull. 25 2002 441 445 (Pubitemid 40044660)
17. A. Zeitvogel, R. Baumann, and A. Starzinski-Powitz Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model Am. J. Pathol. 159 2001 1839 1852 (Pubitemid 33062526)
18. S.K. Banu, J. Lee, A. Starzinski-Powitz, and J.A. Arosh Gene expression profiles and functional characterization of human immortalized endometriotic epithelial and stromal cells Fertil. Steril. 90 2008 972 987
19. S.K. Banu, A. Starzinski-Powitz, V.O. Speights, R.C. Burghardt, and J.A. Arosh Induction of peritoneal endometriosis in nude mice with use of human immortalized endometriosis epithelial and stromal cells: a potential experimental tool to study molecular pathogenesis of endometriosis in humans Fertil. Steril. 91 2009 2199 2209
20. K. Vouk, T. Šmuc, C. Guggenberger, M. Ribič Pucelj, J. Šinkovec, B. Husen, H. Thole, P. Houba, C. Thaete, J. Adamski, and T. Lanišnik Rižner Novel estrogen-related genes and potential biomarkers of ovarian endometriosis identified by differential expression analysis J. Steroid Biochem. Mol. Biol. 125 2011 231 242
21. T. Lanišnik Rižner, T. Šmuc, R. Rupreht, J. Šinkovec, and T.M. Penning AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer Mol. Cell. Endocrinol. 248 2006 126 135
22. J. Vandesompele, K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, and F. Speleman Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol. 3 2002 research0034.1-research0034.11
23. S.A. Bustin, V. Benes, J.A. Garson, J. Hellemans, J. Huggett, M. Kubista, R. Mueller, T. Nolan, M.W. Pfaffl, G.L. Shipley, J. Vandesompele, and C.T. Wittwer The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments Clin. Chem. 55 2009 611 622
24. J.F. Couture, L. Cantin, P. Legrand, V. Luu-The, F. Labrie, and R. Breton Expression, crystallization and preliminary X-ray analysis of human and rabbit 20alpha-hydroxysteroid dehydrogenases in complex with NADP(H) and various steroid substrates Acta Crystallogr. D: Biol. Crystallogr. 58 2002 135 139 (Pubitemid 34099066)
25. P. Brožič, T. Šmuc, S. Gobec, and T. Lanišnik Rižner Phytoestrogens as inhibitors of the human progesterone metabolizing enzyme AKR1C1 Mol. Cell. Endocrinol. 259 2006 30 42 (Pubitemid 44419585)
26. J.M Naumann, A. Zöllner, C.A. Drgan, J. Messinger, J. Adam, and M. Bureik Biotechnological production of 20-alpha-dihydrodydrogesterone at pilot scale Appl. Biochem. Biotechnol. 165 2011 190 203
27. Z. Zsoldos, D. Reid, A. Simon, B.S. Sadjad, and A.P. Johnson eHiTS: an innovative approach to the docking and scoring function problems Curr. Protein Pept. Sci. 7 2006 421 435 (Pubitemid 44524491)
28. Z. Zsoldos, D. Reid, A. Simon, S.B. Sadjad, and A.P. Johnson eHiTS: a new fast, exhaustive flexible ligand docking system J. Mol. Graph. Model. 26 2007 198 212 (Pubitemid 46977244)
29. T. Šmuc, N. Hevir, M. Ribic-Pucelj, B. Husen, H. Thole, and T. Lanišnik Rižner Disturbed estrogen and progesterone action in ovarian endometriosis Mol. Cell. Endocrinol. 301 2009 59 64
30. C. Barbier, H.J. Kloosterboer, and D.G. Kaufman Effects of tibolone metabolites on human endometrial cell lines in co-culture Reprod. Sci. 15 2008 75 82 (Pubitemid 351903554)
31. D.R. Bauman, S.I. Rudnick, L.M. Szewczuk, Y. Jin, S. Gopishetty, and T.M. Penning Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: potential antineoplastic agents that work independently of cyclooxygenase isozymes Mol. Pharmacol. 67 2005 60 68 (Pubitemid 40069966)
32. K.K. Sharma, A. Lindqvist, X.J. Zhou, R.J. Auchus, T.M. Penning, and S. Andersson Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues Mol. Cell. Endocrinol. 248 2006 79 86
33. M.C. Byrns, S. Steckelbroeck, and T.M. Penning An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3alpha-HSD, type 5 17beta-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies Biochem. Pharmacol. 75 2008 484 493 (Pubitemid 350298472)
34. Y. Jin, S.E. Stayrook, R.H. Albert, N.T. Palackal, T.M. Penning, and M. Lewis Crystal structure of human type III 3alpha-hydroxysteroid dehydrogenase/bile acid binding protein complexed with NADP(+) and ursodeoxycholate Biochemistry 40 2001 10161 10168 (Pubitemid 32800122)
35. http://www.medicines.ie/medicine/5163/SPC/Duphaston (accessed 23.12.10).
36. http://www.medicines.ie/medicine/13192/SPC/Provera+Tablets+2. 5mg%2c+5mg+%26+10mg+(Low+Dose) (accessed 23.12.10).
37. B.P. Schlegel, K. Ratnam, and T.M. Penning Retention of NADPH-linked quinone reductase activity in an aldo-keto reductase following mutation of the catalytic tyrosine Biochemistry 37 1998 11003 11011 (Pubitemid 28368925)
38. Y. Jin, and T.M. Penning Molecular docking simulations of steroid substrates into human cytosolic hydroxysteroid dehydrogenases (AKR1C1 and AKR1C2): insights into positional and stereochemical preferences Steroids 71 2006 380 391 (Pubitemid 43675668)